We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
WHX Labs Dubai 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Complement Attacks Brain Cells After Mild Injury

By Biotechdaily staff writers
Posted on 07 Nov 2002
A study has shown that mild injury to the brain such as that caused by brief seizures, minimal head trauma or stroke, or transient anoxia increases the susceptibility of neurons to attack and destruction by complement, which can lead to neurodegeneration and diseases such as Alzheimer's. This information was published in the October 24, 2002, issue of Neuron.

Investigators from Duke University Medical Center (Durham, NC, USA) exposed cultures of neurons and astrocytes to modest levels of glutamate, as might be generated by a mild insult to the brain. The cultures were then exposed to activated complement proteins, which selectively killed the neurons. The damage was found to be caused by the membrane attack pathway of complement. Glutamate treatment sensitized neurons, but not astrocytes, to attack by complement.

The complement immune system pathway consists of an "early activation” pathway that can be protective in Alzheimer's disease, and a "terminal” pathway, in which the proteins combine to create a "membrane attack complex.” It is the terminal pathway and the membrane attack complex that damage neurons sensitized to complement attack by mild brain insult.

"Basically, we have discovered how an insult like transient ischemic attacks, minimal drop in blood pressure, or a minimal blow to the head could facilitate the transition from the early activation pathway to the terminal membrane attack pathway, and transform a protective effect into a damaging effect on the brain,” explained senior author Dr. James O. McNamara, professor and chairman of Duke's department of neurobiology.





Related Links:
Duke Univ

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Gold Member
Hybrid Pipette
SWITCH

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
07 Nov 2002  |   BioResearch

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
07 Nov 2002  |   BioResearch

New Method Simplifies Preparation of Tumor Genomic DNA Libraries
07 Nov 2002  |   BioResearch